{"disease":{"id":"partial-seizures-with-secondary-generalization","name":"partial seizures with secondary generalization"},"drugs":{"marketed":[{"drug_id":"bat","indication_name":"Treatment of partial-onset seizures with and without secondary generalization in patients 12 years of age and older with epilepsy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bat","generic_name":"bat","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Unknown","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03083665","title":"A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":449,"lead_sponsor_name":"UCB Biopharma SRL","has_results":true},{"nct_id":"NCT03250377","title":"A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":207,"lead_sponsor_name":"UCB Biopharma SRL","has_results":true},{"nct_id":"NCT06960811","title":"Epileptic Psychoses and Their Link With Ictal Emotions and Consciousness","phase":"","overall_status":"COMPLETED","enrollment_count":117,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT03685630","title":"A Study to Evaluate the Safety and Tolerability of Intravenous Brivaracetam (BRV) as Replacement for Oral Brivaracetam in Japanese Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"UCB Biopharma S.P.R.L.","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}